MARY KAY INC. – FDA Inspection, Oct 27, 2023

Record Details

This FDA Inspection record concerns MARY KAY INC., with an inspection on October 27, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: MARY KAY INC.
Inspection Date: October 27, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Kevin T. Nguyen (Company Rep)

View Company Profile

ID · 1e1fb98c-9261-4c52-ac32-ba89a58fce7e

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1222112
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued

FDA Citations

21 CFR 211.67(b)(5)Cleaning SOPs/equipment protection
21 CFR 211.67(b)(5)Cleaning SOPs/equipment protection

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore MARY KAY INC.

FDA Inspection

MARY KAY INC.October 27, 2023